compounded glp-1 atlanta / GIP 12 Week Compounded GLP-1 Program
Description
It cannot be legally purchased without a medical consultation
A 2024 double-blind randomized trial of 156 participants with early Parkinsons disease found that participants receiving a GLP-1 drug, lixisenatide, showed no progression of motor symptoms, compared to a measurable worsening on standard motor scales in the placebo group
This timeline is longer than Ozempic
Modulation of Chronic Inflammatory Signalling Chronic low-grade inflammation is a recognised and well-characterised driver of carcinogenesis
and reduce likelihood of longterm weight maintenance (especially if GLP1 therapy is stopped)
